Status:
COMPLETED
Risk of Hypoglycemia in Type 2 Diabetes
Lead Sponsor:
University of Giessen
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to establish the risk and frequency of non-symptomatic hypoglycemia in type 2 diabetes under previous therapy with glibenclamide. Participants will be monitored via a continuo...
Detailed Description
The day-to-day change of blood glucose is associated with the frequency of vascular complications and the quality of life of diabetic patients. In this study the frequency of hypoglycemic events in co...
Eligibility Criteria
Inclusion
- Type 2 diabetes on glibenclamide with or without
- Glycated hemoglobin ≤ 7.5%
- Stable dosage for three weeks
Exclusion
- HbA1c \> 7.5%
- Fasting C-peptide below normal
- Concurrent infectious disease
- Pregnancy
- Malignant disease
- Inability to give informed consent
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2016
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00734669
Start Date
July 1 2008
End Date
October 1 2016
Last Update
October 26 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.